Table 1.
Subject and EEG data characteristics
| Patient | Group | Age | Gender | Medication | Neurodevelopmental comorbidities | Duration from first seizure (years) | Duration seizure‐free (years) | Wake EEG length (s) | Sleep EEG length (s) | Centrotemporal spikes (Y/N)/lateralization (L/R/B) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BECTS | 13.7 | F | None | ADHD | 7.03 | 4.25 | 200 | 200 | Y/B |
| 2 | BECTS | 11.8 | M | LEV | None | 1.67 | 1.42 | 200 | 200 | N |
| 3 | BECTS | 14.7 | M | None | Learning disorder | 4.34 | 0 | 200 | 200 | Y/L |
| 4 | BECTS | 14.9 | M | None | ADHD | 9.06 | 3.17 | 200 | 200 | Y/L |
| 5 | BECTS | 13.3 | M | LEV | None | 4.27 | 2.17 | 187 | 200 | Y/R |
| 6 | BECTS | 9.1 | F | LEV, LTG | ADHD, Learning disorder, Auditory processing disorder | 0.89 | 0.08 | 200 | 200 | Y/B |
| 7 | BECTS | 9.8 | M | OXC | None | 0.10 | 0 | 134 | 200 | Y/R |
| 8 | BECTS | 12.8 | F | None | ADD | 4.97 | 2.83 | 200 | 200 | N |
| 9 | BECTS | 8.0 | M | None | None | 2.64 | 2.42 | 200 | 200 | Y/B |
| 10 | BECTS | 14.8 | M | None | None | 6.89 | 3.33 | 200 | N/A | N |
| 11 | BECTS | 11.0 | F | None | None | 2.31 | 0.17 | 200 | 199 | Y/B |
| 12 | BECTS | 9.0 | M | None | None | 0.71 | 0.33 | 131 | 105 | Y/B |
| 13 | BECTS | 10.9 | M | None | None | 2.58 | 0.83 | 200 | 185 | Y/B |
| 14 | BECTS | 11.5 | M | None | None | 1.81 | 1.67 | N/A | 200 | Y/L |
| 15 | BECTS | 11.6 | M | LEV | None | 0.72 | 0.17 | 200 | 113 | N |
| 16 | BECTS | 10.5 | F | LEV | Learning Disorder | 4.07 | 0.33 | 188 | 103 | Y/R |
| 17 | BECTS | 10.4 | M | LEV | Language Disorder | 2.48 | 2.17 | 198 | 161 | Y/B |
| 18 | BECTS | 11.9 | M | LEV | None | 4.53 | 2 | 200 | 200 | N |
| 19 | BECTS | 11.6 | M | None | None | 1.15 | 1.17 | 200 | 200 | Y/R |
| 20 | BECTS | 9.9 | M | None | None | 2.29 | 0.5 | 200 | 200 | Y/B |
| 21 | BECTS | 11.3 | M | None | ADHD, Learning disorder | 0.48 | 0.08 | 200 | 200 | Y/B |
| 22 | BECTS | 9.6 | M | None | Dyslexia, ADHD | 0.61 | 0.58 | 134 | 200 | Y/B |
| 1 | HC | 9.0 | F | N/A | None | 200 | 200 | |||
| 2 | HC | 7.2 | F | N/A | None | 200 | N/A | |||
| 3 | HC | 7.9 | M | N/A | None | 200 | N/A | |||
| 4 | HC | 8.3 | M | N/A | ADHD | 200 | N/A | |||
| 5 | HC | 12.9 | F | N/A | None | 200 | 200 | |||
| 6 | HC | 12.2 | F | N/A | None | 192 | 200 | |||
| 7 | HC | 14.2 | F | N/A | None | 200 | 200 | |||
| 8 | HC | 9.4 | F | N/A | None | 200 | 200 | |||
| 9 | HC | 9.4 | F | N/A | None | 127 | 35 s | |||
| 10 | HC | 13.6 | F | N/A | Learning disorder | 189 | 200 | |||
| 11 | HC | 9.4 | M | N/A | None | 128 | 200 |
LEV: levetiracetam; LTG: lamotrigine; OXC: oxcarbazepine; ADHD: attention deficit hyperactivity disorder; Y: yes; N: No; L: left; R: right; B: bilateral.